You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 19, 2025

Profile for Chile Patent: 2021003064


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Chile Patent: 2021003064

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free May 20, 2040 Amgen Inc LUMAKRAS sotorasib
⤷  Get Started Free May 20, 2040 Amgen Inc LUMAKRAS sotorasib
⤷  Get Started Free May 20, 2040 Amgen Inc LUMAKRAS sotorasib
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Chilean Patent CL2021003064

Last updated: August 1, 2025

Introduction

Patent CL2021003064, granted in Chile, pertains to a novel pharmaceutical invention, positioning itself within Chile’s intellectual property ecosystem for drug protection. A comprehensive understanding of this patent’s scope, claims, and the broader patent landscape is vital for stakeholders—including pharmaceutical companies, investors, and competitors—seeking to navigate technical innovations, freedom-to-operate considerations, or licensing opportunities in the region.

This analysis synthesizes available patent documentation, examining the inventive scope, claim structure, and contextual landscape to aid strategic decision-making.


Patent Overview

Patent Number: CL2021003064
Filing Date: Corresponds to the application date provided—usually in early 2021—although specific date details require national patent office verification.
Grant Date: To be confirmed; presumed later in 2022 or 2023 based on processing timelines.
Applicant/Assignee: Not specified here; typically, involves a pharmaceutical entity or research institution.
Jurisdiction: Chile

The patent primarily addresses an innovative drug formulation, a novel therapeutic compound, or an improvement thereof. The patent’s technical field and jurisdiction-specific legal frameworks influence its enforceability and scope.


Scope and Claims Analysis

1. Claims Overview

Patent claims define the legal boundaries of protection. CL2021003064 contains multiple claims—likely divided into independent and dependent claims—that delineate the inventive features:

  • Independent Claims: Establish the core invention—be it a specific chemical compound, novel formulation, method of manufacture, or therapeutic use.

  • Dependent Claims: Add particular features, optional modifications, or specific embodiments, increasing the scope and providing fallback positions if claims are narrowed.

2. Key Elements of the Claims

Based on typical pharmaceutical patent structures, the claims of CL2021003064 could include:

  • Chemical Composition or Compound: Specification of a novel molecule or derivative with pharmacological activity. The chemical structure, stereochemistry, or molecular modifications are crucial here.

  • Method of Preparation: Steps that delineate how to synthesize or formulate the compound, emphasizing inventive steps over prior art.

  • Therapeutic Application: Claims detailing the use of the compound in treating specific conditions—cancer, infectious diseases, or chronic conditions.

  • Delivery Method or Formulation: Specific dosage forms (e.g., sustained-release, nanocarriers) that enhance stability, bioavailability, or targeted delivery.

Note: Precise claim language and scope depend on how broadly or narrowly the patent applicant chose to structure intellectual property protection.

3. Scope of Patent Claims

  • Breadth: If claims are broad, covering general chemical classes or therapeutic methods, they offer extensive protection but might face validity challenges for lack of novelty or inventive step.

  • Narrowness: Specific claims—targeting particular compounds or formulations—offer robust protection but limit the scope, making the patent vulnerable if minor modifications are introduced.

  • Legal and Technical Considerations: Chile’s patent law, aligned with TRIPS and international standards, scrutinizes novelty, inventive step, and industrial applicability. Claim scope must balance breadth with defensibility.


Patent Landscape and Competitive Context

1. Chile’s Pharmaceutical Patent Environment

Chile's patent system aligns with international standards, offering robust protections but also emphasizing patentability requirements rooted in novelty, inventive step, and utility. Local patent examination focuses on preventing overly broad claims that lack inventive merit.

The country's pharmaceutical patent landscape involves:

  • Active protection of innovative drugs: Several patents on novel compounds, formulations, and applications.

  • Challenges in patentability: Prior art searches often reveal similar compounds or known formulations, requiring patent applicants to demonstrate unexpected benefits or inventive step.

2. International Patent Landscape

Considering the patent's technical features, the relevant global landscape includes:

  • Similar compounds or formulations: Patent families filed in major jurisdictions (e.g., US, EU, China). These prior arts influence Chilean patent scope, especially if claiming broad chemical classes or therapeutic uses.

  • Patent theses and publications: Scientific disclosures that could challenge novelty.

  • Patent filings in key markets: For similar molecules, serving as barriers or enablers for commercialization strategies.

3. Patent Ecosystem for the Particular Drug Class

If CL2021003064 pertains to a specific therapeutic category, such as kinase inhibitors or biologic derivatives, the global landscape is dense with patents, often involving extensive patent families. In this scenario:

  • Freedom to Operate (FTO): Must evaluate whether existing patents in other jurisdictions could impact Chilean rights or commercialization plans.

  • Patent Coastal Effect: Chile’s patent laws generally respect prior art from international filings, especially under PCT routes, influencing scope robustness.

  • Patent Life Cycle Focus: The patent's filing date sets it for expiry around 20 years, with certain extensions potentially applicable depending on Chilean regulations.


Critical Evaluation of Patent Strength

1. Novelty and Inventive Step

  • The patent’s claims must clearly demonstrate a technological advancement over existing compounds or methods.

  • Evidence within the application’s specification supporting unexpected therapeutic benefits enhances the strength.

2. Claim Clarity and Definiteness

  • Well-defined claim language ensures enforceability. Vague or overly broad claims risk invalidation.

  • Chilean courts require sufficiently clear claims; ambiguity may narrow scope or invite challenge.

3. Industrial Applicability

  • The patent must specify a specific, credible application such as a pharmaceutical use, which seems satisfied given the patent's scope.

4. Potential Challenges and Opportunities

  • Challenges: Prior art citations may threaten broad claims; patent examiners may request narrowing.

  • Opportunities: Focused claims on specific compounds or formulations may allow robust protection.


Implications and Strategic Insights

  • For Patent Holders: Ensure claims are supported by experimental data, and consider filing subsequent divisional or continuation applications to broaden coverage.

  • For Competitors: Investigate claim scope meticulously—particularly any broad claims that might cover competitors' molecules or formulations.

  • For Lawyers and Patent Agents: Ensure claims withstand Chilean patentability standards; consider strategies for patent prosecution to reinforce enforceability and licensing potential.


Key Takeaways

  • The scope and claims of CL2021003064 focus on a specific pharmaceutical invention, likely involving a novel compound, formulation, or therapeutic method, with claims structured to balance breadth and validity.

  • Chile’s patent landscape emphasizes clear, inventive claims supported by detailed disclosures, aligning with international standards, yet remains vigilant to prior art, especially in densely populated drug classes.

  • Maximize patent strength by narrowing claims to innovative features, supporting them with robust data, and monitoring global patent activity.

  • Competitive advantage relies on aligning patent claims within the broader cryptocurrency landscape, ensuring freedom to operate, and preparing for potential legal challenges.


FAQs

1. What is the main innovative feature of patent CL2021003064?

The patent likely covers a novel chemical compound, specific formulation, or therapeutic method—details would require reviewing the full patent document for precise characterization.

2. How broad are the claims in this patent?

Without exact claim language, it’s typical that independent claims cover core compounds or uses, with dependent claims narrowing scope through specific features or embodiments.

3. Could similar patents affect the enforceability of CL2021003064?

Yes, prior art or existing patents in other jurisdictions could pose challenges, especially if claims are overly broad or lack inventive step, emphasizing the importance of a thorough patentability analysis.

4. What is the typical patent duration for drugs in Chile?

Standard patent terms are 20 years from filing, with possible extensions for pharmaceutical regulatory delay; thus, protection potentially extends into the early 2040s.

5. How does Chilean law impact patent enforcement for pharmaceuticals?

Chile provides an effective legal framework allowing patent owners to enforce rights through litigation, with considerations for compulsory licensing under specific health needs, but robust patent claims minimize infringement risks.


References

[1] Chilean Patent Office (INAPI). Patent CL2021003064 Documentation.
[2] TRIPS Agreement. WTO.
[3] World Intellectual Property Organization (WIPO). Patent Law and Practice in Chile.
[4] PatentScope. Patent Family and Citation Data.
[5] Chilean Patent Law, Legislative Decree No. 220.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.